HCRN Directory

Quality of Life/Cancer Control

A Phase II Trial of Olanzapine (Zyprexa) and Palonosetron (Aloxi) for the Prevention of Chemotherapy Induced Nausea and Vomiting

Status

Cancer Types

Locations

Fluoxetine versus Placebo in Advanced Cancer Outpatients: A Placebo-Controlled, Double-Masked Trial

Status

Cancer Types

Quality of Life/Cancer Control

Locations

Clinicians’ Assessment Of Quality Of Life (QoL) In Outpatients With Advanced Cancer: How Accurate Is Our Prediction?

Status

Cancer Types

Quality of Life/Cancer Control

Locations

A Phase I Trial of Olanzapine (ZYPREXA) For the Prevention of Delayed Emesis in Cancer Patients Receiving Chemotherapy

Status

Cancer Types

Quality of Life/Cancer Control

Locations

A Phase II Trial of Olanzapine (Zyprexa) for the Prevention of Delayed Emesis in Cancer Patients Receiving Chemotherapy

Status

Cancer Types

Quality of Life/Cancer Control

Locations

A phase II trial of olanzapine and palonosetron for the prevention of chemotherapy induced nausea and vomiting (CINV)

Status

Cancer Types

Quality of Life/Cancer Control

Locations

Phase III double blind placebo controlled crossover study evaluating a 5HT3 antagonist + dexamethasone +/- aprepitant in germ cell tumor patients receiving 5 day cisplatin combination chemotherapy

Status

Cancer Types

Quality of Life/Cancer Control

Locations

Phase II study of fosaprepitant plus 5HT3 receptor antagonists plus dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy

Status

Cancer Types

Quality of Life/Cancer Control

Locations

Phase II study of fosaprepitant +5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy

Status

Cancer Types

Quality of Life/Cancer Control

Locations

A Pilot Exploration of the Antiemetic Activity of Olanzapine for the Relief of Nausea in Patients with Advanced Cancer and Pain

Status

Cancer Types

Quality of Life/Cancer Control

Locations

Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy

Status

Cancer Types

Quality of Life/Cancer Control

Locations

Assessment of Quality of Life in Outpatients with Advanced Cancer: The Accuracy of Clinician Estimations and the Relevance of Spiritual Well-Being

Status

Cancer Types

Quality of Life/Cancer Control

Locations

Fluoxetine versus Placebo in Advanced Cancer Outpatients: A Double-Blinded Trial

Status

Cancer Types

Quality of Life/Cancer Control

Locations

A phase I trial of olanzapine (Zyprexa) for the prevention of delayed emesis in cancer patients

Status

Cancer Types

Quality of Life/Cancer Control

Locations

Trial of Antidepressants for Mildly Depressed Cancer Patients Should Have Been Reported in a Manner Allowing Independent Evaluation of Investigators’ Claims

Status

Cancer Types

Quality of Life/Cancer Control

Locations

A Phase II Trial of Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting

Status

Cancer Types

Quality of Life/Cancer Control

Locations

A Phase II Trial of Olanzapine, Dexamethasone and Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting

Status

Cancer Types

Quality of Life/Cancer Control

Locations

Palonosetron plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy for germ cell cancer

Status

Cancer Types

Quality of Life/Cancer Control

Locations

Randomized, Double-Blind, Placebo-Controlled, Phase III Cross-Over Study Evaluating the Oral Neurokinin-1 Antagonist Aprepitant in Combination With a 5HT3 Receptor Antagonist and Dexamethasone in Patients With Germ Cell Tumors Receiving 5-Day Cisplatin Combination Chemotherapy Regimens

Status

Cancer Types

Quality of Life/Cancer Control

Locations